查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1400995

肝病治療市場，按治療類型、疾病類型、國家和地區分類 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Liver Disease Treatment Market, by Treatment Type, Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 266 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年肝病治療市場規模為223,0042萬美元，2023年至2030年CAGR為6.42%。

肝病治療市場動態

肝病患者數的增加推動了市場的成長

肝臟疾病盛行率的增加、飲酒量的增加以及不良的飲食習慣是預期推動肝臟疾病治療市場成長的主要因素。例如，根據 2021 年 6 月發表在《臨床肝病》雜誌上的研究報告，慢性肝病 (CLD) 影響全球近 15 億人，是全球疾病和死亡的主要原因之一。此外，根據美國肝病研究協會 2021 年 6 月發布的研究，非酒精性脂肪肝病 (NAFLD) 是肝病的主要原因，佔肝病病例的 59%，其次是丙型肝炎 (9 %）、B型肝炎（ 29%）和酒精性肝病（ALD）（2%）。此外，2022年10月發表在《臨床與分子肝病學》上的一項研究預測，到2040年，全球非酒精性脂肪肝病（NAFLD）的盛行率將達到55.7%。因此，肝病發病率的上升推動了整個產業的發展。

肝病治療市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球肝病治療市場在預測期內（2023-2030 年）每年將以 6.42% 左右的CAGR成長

由於肝病患者數量的增加推動市場成長，肝病治療市場預計將以顯著的速度成長

根據治療類型細分，預計抗病毒藥物將在 2022 年顯示最大的市場佔有率

根據疾病類型細分，肝炎是 2022 年的主要疾病類型

按地區分類，北美是 2022 年的主要收入來源

肝病治療市場-細分分析：

全球肝病治療市場根據治療類型、疾病類型和地區進行細分。

市場依治療類型分為：免疫抑制劑、抗病毒藥物、免疫球蛋白、疫苗、標靶治療、皮質類固醇和化療藥物。由於抗病毒藥物具有眾多優勢，該行業支出的大幅增加對該細分市場產生了積極影響。此外，醫療保健成本的上升、公眾意識的提高以及乙型肝炎和丙型肝炎患病率的增加是預計支持市場擴張的其他重要方面。

市場依疾病類型分為以下幾類：自體免疫疾病、肝炎、非酒精性脂肪肝病（NAFLD）、遺傳性疾病、癌症等。由於製藥錯誤、過量飲酒、自體免疫疾病、病毒感染和非酒精性脂肪性肝炎，肝組織的發炎狀態在過去幾年中顯著惡化。

肝病治療市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美地區預計將成長。 2022年，肝病治療市場將由北美主導。特別是在中國、印度和韓國，對先進和創新肝病治療藥物的需求不斷成長，是推動該行業發展的關鍵因素之一。此外，這種成長背後的主要因素之一可能是 NAFLD 和肝炎的盛行率不斷上升、缺乏專業知識以及該地區醫療基礎設施薄弱。

肝病治療市場-競爭格局：

公司透過多種管道銷售產品，包括企業網站、電子商務網站、零售商、分銷​​商和最終消費者。產品製造商在多個方面競爭，包括產品成本、性能、產品製造、技術、聲譽和可用性。企業用來擴大影響力和擴大市場佔有率的一些主要類型包括新產品發布、分銷網路開發、研發支出以及併購。例如，2023 年 1 月，武田 (Takeda) 和 Arrowhead Pharmaceuticals Inc. 發布了實驗性 Fazirsiran 用於治療與 α-1 抗胰蛋白酶缺乏症 (AATD-LD) 相關的肝病的 2 期 SEQUOIA 臨床研究的 Topline資料。

最近的發展：

據 Ipsen 稱，2023 年 6 月，經 FDA 批准，從 12 個月大開始患有 Alagille 症候群 (ALGS) 的患者現在可以使用 Bylvay (R) (odevixibat) 治療膽汁淤積性瘙癢。 Bylvay 是一種每日一次、最低限度全身暴露、局部作用的迴腸膽汁酸轉運抑制劑 (IBATi)，全身暴露最小。在美國和歐洲，Bylvay 於 2021 年被授權成為首個治療進行性家族性肝內膽汁淤積 (PFIC) 患者膽汁淤積性瘙癢的藥物。對於符合條件的 ALGS 患者，憑處方即可立即獲得 Bylvay。

目錄

第1章：肝病治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按治療類型分類的肝病治療市場片段
    • 按疾病類型分類的肝病治療市場片段
    • 按國家/地區分類的肝病治療市場片段
    • 按地區分類的肝病治療市場片段
  • 競爭洞察

第 3 章：半導體記憶體主要市場趨勢

  • 肝病治療市場促進因素
    • 市場促進因素的影響分析
  • 肝病治療市場限制
    • 市場限制影響分析
  • 肝病治療市場機會
  • 肝病治療市場未來趨勢

第 4 章：半導體記憶體產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：肝病治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：肝病治療市場格局

  • 2022 年肝病治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：肝病治療市場 - 依治療類型

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • 免疫抑制劑
    • 抗病毒藥物
    • 免疫球蛋白
    • 疫苗
    • 標靶治療
    • 皮質類固醇
    • 化療藥物

第 8 章：肝病治療市場 - 依疾病類型

  • 概述
    • 按疾病類型分類的細分市場佔有率分析
    • 自體免疫疾病
    • 肝炎
    • 非酒精性脂肪肝（NAFLD）
    • 遺傳性疾病
    • 癌症
    • 其他

第 9 章：肝病治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美半導體記憶體主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按治療類型）
    • 北美市場規模和預測（按疾病類型）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲半導體記憶體主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按治療類型）
    • 歐洲市場規模與預測（按疾病類型）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區半導體記憶體主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按治療類型）
    • 亞太地區市場規模與預測（按疾病類型）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲半導體記憶體主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按治療類型）
    • 拉丁美洲市場規模與預測（按疾病類型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲半導體記憶體主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按治療類型）
    • 中東和非洲市場規模及預測（按疾病類型）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 半導體記憶體產業

  • 競爭儀表板
  • 公司簡介
    • Vertex Pharmaceuticals
    • Takeda Pharmaceuticals
    • Shire (now part of Takeda Pharmaceuticals)
    • Roche
    • Pfizer
    • Novartis
    • Madrigal Pharmaceuticals
    • Intercept Pharmaceuticals
    • Gilead Sciences
    • Genfit
    • Durect Corporation
    • Conatus Pharmaceuticals
    • Bristol-Myers Squibb
    • Alnylam Pharmaceuticals
    • Allergan

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1959

REPORT HIGHLIGHT

Liver Disease Treatment market size was valued at USD 22,300.42 Million in 2022, expanding at a CAGR of 6.42% from 2023 to 2030.

Treatment for liver disease refers to medical measures taken to control and lessen illnesses that have an impact on the structure or operation of the liver. Depending on the exact liver ailment, several treatment modalities are used, but they often entail modifying one's lifestyle, taking medications, and in extreme circumstances, undergoing surgery or a liver transplant. Hepatitis, cirrhosis, fatty liver disease, and liver cancer are examples of common liver illnesses. Controlling inflammation, treating symptoms, avoiding consequences, and addressing underlying causes are frequently the objectives of treatment. To improve results and maintain liver function, early diagnosis, and prompt treatments are essential.

Liver Disease Treatment Market Dynamics

The rise in the number of people with liver diseases propelled the market growth

The increased prevalence of liver disorders, the rise in alcohol usage, and poor eating habits are the main factors anticipated to propel growth in the market for therapies for liver diseases. For instance, according to a research report that was published in the Clinical Liver Disease journal in June 2021, chronic liver disease (CLD), which affects nearly 1.5 billion people worldwide, is one of the major causes of sickness and mortality globally. Furthermore, according to research published in June 2021 by the American Association for the Study of Liver Diseases, non-alcoholic fatty liver disease (NAFLD) is the leading cause of hepatic illness, accounting for 59% of cases, followed by hepatitis C (9%), hepatitis B (29%), and alcoholic liver disease (ALD) (2%). Furthermore, a research published in Clinical and Molecular Hepatology in October 2022 predicted that by 2040, the prevalence of non-alcoholic fatty liver disease (NAFLD) will be 55.7% worldwide. As a result, rising liver ailments have fueled the industry as a whole.

Liver Disease Treatment Market- Key Insights

As per the analysis shared by our research analyst, the Global Liver Disease Treatment market is estimated to grow annually at a CAGR of around 6.42% over the forecast period (2023-2030)

The Liver Disease Treatment market is projected to grow at a significant rate due to the rise in the number of people with liver diseases to propel the market growth

Based on Treatment Type segmentation, Antiviral Drugs was predicted to show maximum market share in the year 2022

Based on Disease Type segmentation, Hepatitis was the leading Disease Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Liver Disease Treatment Market- Segmentation Analysis:

The Global Liver Disease Treatment market is segmented on the basis of Treatment Type, Disease Type, and Region.

The market is divided into categories based on Treatment Type: Immunosuppressants, Antiviral Drugs, Immunoglobulins, Vaccines, Targeted Therapy, Corticosteroids, and Chemotherapy Drugs. Positive effects are being produced on the antiviral drug's sub-segment by the significantly increasing expenditures in the sector, largely because of its numerous advantages. Additionally, rising healthcare costs, increased public awareness, and an increase in the prevalence of hepatitis B and C are other significant aspects anticipated to support market expansion.

The market is divided into categories based on Disease Type: Autoimmune Diseases, Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), Genetic Disorders, Cancer, and Others. Due to pharmaceutical mistakes, excessive alcohol intake, autoimmune disorders, viral infections, and nonalcoholic steatohepatitis, the inflammatory status of the liver tissue has significantly worsened during the past several years.

Liver Disease Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America region is expected to grow. In 2022, the market for Liver Disease Treatments will be dominated by North America. The extensively increasing need for advanced and innovative liver disease therapeutics particularly in China, India, and South Korea is one of the key elements boosting the development of the industry. Also, one of the major factors behind this growth can be the increasing prevalence of NAFLD and hepatitis, lack of expertise, and the poor healthcare infrastructure in the region.

Liver Disease Treatment Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary Types used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in January 2023, Topline data from the Phase 2 SEQUOIA clinical research of experimental Fazirsiran for the treatment of liver disease linked to alpha-1 antitrypsin deficiency (AATD-LD) were released by Takeda and Arrowhead Pharmaceuticals Inc.

Recent Developments:

In June 2023, according to Ipsen, individuals with Alagille syndrome (ALGS) starting at 12 months of age can now treat their cholestatic pruritus with Bylvay® (odevixibat), as to an FDA approval. Bylvay is a once-daily, minimally systemically exposed, locally acting ileal bile acid transport inhibitor (IBATi) with minimum systemic exposure. In the United States and Europe, Bylvay was authorized as the first medication for treating cholestatic pruritus in individuals with progressive familial intrahepatic cholestasis (PFIC) in 2021. For qualifying ALGS patients, Bylvay is instantly available with a prescription.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVER DISEASE TREATMENT MARKET KEY PLAYERS

  • Vertex Pharmaceuticals
  • Takeda Pharmaceuticals
  • Shire (now part of Takeda Pharmaceuticals)
  • Roche
  • Pfizer
  • Novartis
  • Madrigal Pharmaceuticals
  • Intercept Pharmaceuticals
  • Gilead Sciences
  • Genfit
  • Durect Corporation
  • Conatus Pharmaceuticals
  • Bristol-Myers Squibb
  • Alnylam Pharmaceuticals
  • Allergan

GLOBAL LIVER DISEASE TREATMENT MARKET, BY TREATMENT TYPE

  • Immunosuppressants
  • Antiviral Drugs
  • Immunoglobulins
  • Vaccines
  • Targeted Therapy
  • Corticosteroids
  • Chemotherapy Drugs

GLOBAL LIVER DISEASE TREATMENT MARKET, BY DISEASE TYPE

  • Autoimmune Diseases
  • Hepatitis
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Genetic Disorders
  • Cancer
  • Others

GLOBAL LIVER DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Liver Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Liver Disease Treatment Market Snippet by Treatment Type
    • 2.1.2. Liver Disease Treatment Market Snippet by Disease Type
    • 2.1.3. Liver Disease Treatment Market Snippet by Country
    • 2.1.4. Liver Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Semiconductor Memory Key Market Trends

  • 3.1. Liver Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Liver Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Liver Disease Treatment Market Opportunities
  • 3.4. Liver Disease Treatment Market Future Trends

4. Semiconductor Memory Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Liver Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Liver Disease Treatment Market Landscape

  • 6.1. Liver Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Liver Disease Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 7.1.2. Immunosuppressants
    • 7.1.3. Antiviral Drugs
    • 7.1.4. Immunoglobulins
    • 7.1.5. Vaccines
    • 7.1.6. Targeted Therapy
    • 7.1.7. Corticosteroids
    • 7.1.8. Chemotherapy Drugs

8. Liver Disease Treatment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Autoimmune Diseases
    • 8.1.3. Hepatitis
    • 8.1.4. Non-alcoholic Fatty Liver Disease (NAFLD)
    • 8.1.5. Genetic Disorders
    • 8.1.6. Cancer
    • 8.1.7. Others

9. Liver Disease Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Semiconductor Memory Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Semiconductor Memory Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Semiconductor Memory Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Semiconductor Memory Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Semiconductor Memory Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Semiconductor Memory Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Vertex Pharmaceuticals
    • 10.2.2. Takeda Pharmaceuticals
    • 10.2.3. Shire (now part of Takeda Pharmaceuticals)
    • 10.2.4. Roche
    • 10.2.5. Pfizer
    • 10.2.6. Novartis
    • 10.2.7. Madrigal Pharmaceuticals
    • 10.2.8. Intercept Pharmaceuticals
    • 10.2.9. Gilead Sciences
    • 10.2.10. Genfit
    • 10.2.11. Durect Corporation
    • 10.2.12. Conatus Pharmaceuticals
    • 10.2.13. Bristol-Myers Squibb
    • 10.2.14. Alnylam Pharmaceuticals
    • 10.2.15. Allergan

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liver Disease Treatment Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Liver Disease Treatment Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Liver Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liver Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Liver Disease Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Treatment Type segment market share analysis, 2022 & 2030
  • FIGURE Treatment Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2022 & 2030
  • FIGURE Disease Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Europe Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Latin America Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Liver Disease Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Germany Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE India Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Brazil Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)